Fireside Chat: Future-Proofing Your Regulatory Strategy – What’s Next for Cannabinoid Drug Policy?
- Forecast upcoming regulatory and political shifts globally, and how they are likely to shape cannabinoid drug approval pathways in the next 12 months
- Explore how companies are successfully managing international regulatory divergence to unlock broader market access for cannabinoid-based therapies
- Gain insights on how to communicate regulatory readiness to investors, partners, and stakeholders to build confidence in long-term development plans